Parkinsonism, Experimental
|
0.300 |
Therapeutic
|
disease |
CTD_human |
A recurrent mutation in PARK2 is associated with familial lung cancer.
|
25640678 |
2015 |
Parkinsonism, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
A recurrent mutation in PARK2 is associated with familial lung cancer.
|
25640678 |
2015 |
Parkinsonism, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
|
10072423 |
1999 |
Parkinsonism, Experimental
|
0.300 |
Therapeutic
|
disease |
CTD_human |
A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
|
10072423 |
1999 |
Parkinsonism, Experimental
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36.
|
11254447 |
2001 |
Parkinsonism, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36.
|
11254447 |
2001 |
Parkinsonism, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down parkin Drosophila melanogaster exposed to oxidative stress stimuli: implication in autosomal recessive juvenile parkinsonism.
|
23046578 |
2013 |
Parkinsonism, Experimental
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down parkin Drosophila melanogaster exposed to oxidative stress stimuli: implication in autosomal recessive juvenile parkinsonism.
|
23046578 |
2013 |
Parkinsonism, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells.
|
26558463 |
2015 |
Parkinsonism, Experimental
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells.
|
26558463 |
2015 |
Parkinsonism, Experimental
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype.
|
10894217 |
2000 |
Parkinsonism, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype.
|
10894217 |
2000 |
Parkinsonism, Experimental
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Parkin disease: a phenotypic study of a large case series.
|
12764051 |
2003 |
Parkinsonism, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Parkin disease: a phenotypic study of a large case series.
|
12764051 |
2003 |
Parkinsonism, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease.
|
16914382 |
2006 |
Parkinsonism, Experimental
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease.
|
16914382 |
2006 |